Glaukos (NYSE: GKOS) insider plans sale of 525 vested shares

Rhea-AI Filing Summary

Glaukos Corporation has a notice of proposed sale under Form 144 by Leana Wen covering 525 shares of common stock, with an aggregate market value of $88,005.75, expected around July 31, 2026. These shares stem from restricted stock vesting on May 30, 2025 and are classified as compensation. Over the prior three months, Wen sold 1,700 common shares on May 1, 2026 for an aggregate value of $247,095.17.

Key Figures

Proposed shares to be sold: 525 shares Aggregate market value of proposed sale: $88,005.75 Proposed sale date: 07/31/2026 +3 more

6 metrics

Proposed shares to be sold 525 shares Common stock covered by Form 144 notice

Aggregate market value of proposed sale $88,005.75 Estimated value of 525 common shares

Proposed sale date 07/31/2026 Expected date for sale of 525 shares on NYSE

Restricted stock vesting date 05/30/2025 Date underlying 525 compensation shares vested

Shares sold in past 3 months 1,700 shares Common stock sale reported on 05/01/2026

Aggregate value of past 3-month sale $247,095.17 Value of 1,700 common shares sold 05/01/2026

Key Terms

Form 144, Restricted Stock Vesting, aggregate market value, Compensation

4 terms

Form 144 regulatory

"has a notice of proposed sale under Form 144 by Leana Wen"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 05/30/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"an aggregate market value of $88,005.75, expected around July 31, 2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Compensation financial

"and are classified as compensation"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/31/2026 - 04:23 PM Accepted by SEC EDGAR 07/31/2026 - 04:22 PM Learn about SEC filing dates

FAQ

What does Glaukos (GKOS) disclose in this Form 144 filing?

Glaukos discloses that Leana Wen intends to sell 525 common shares of the company, valued in total at $88,005.75, following the vesting of restricted stock granted as compensation.

How many Glaukos (GKOS) shares are proposed to be sold and at what value?

The filing covers a proposed sale of 525 Glaukos common shares with an aggregate market value of $88,005.75. These shares are to be sold on or about July 31, 2026 through a broker.

What is the source of the Glaukos (GKOS) shares covered by this Form 144?

The 525 Glaukos common shares come from restricted stock vesting that occurred on May 30, 2025. The filing classifies the transaction type as Compensation from the issuer.

What Glaukos (GKOS) stock sales occurred in the past three months for this filer?

Over the past three months, the filer sold 1,700 Glaukos common shares on May 1, 2026 for an aggregate value of $247,095.17, as reported in the recent transactions section.

Who is the reporting person in this Glaukos (GKOS) Form 144 and which broker is listed?

The reporting person is Leana Wen, associated with Glaukos Corporation. The broker listed for the proposed sale is Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	525	88005.75	58983937	07/31/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/30/2025	Restricted Stock Vesting	Issuer			525	05/30/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leana Wen 1 Glaukos Way Aliso Viejo CA 92656	Common	05/01/2026	1700	247095.17

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)